Annual Revenue
$1.19 M
0.00%
31 December 2023
Summary:
Iovance Biotherapeutics annual revenue is currently $1.19 millionIOVA annual revenue is now at all-time high.IOVA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$58.55 M
+$27.45 M+88.24%
30 September 2024
Summary:
Iovance Biotherapeutics quarterly revenue is currently $58.55 million, with the most recent change of +$27.45 million (+88.24%) on 30 September 2024. Over the past year, it has increased by +$58.09 million (+12384.86%). IOVA quarterly revenue is now at all-time high.IOVA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$90.86 M
+$58.09 M+177.24%
30 September 2024
Summary:
Iovance Biotherapeutics TTM revenue is currently $90.86 million, with the most recent change of +$58.09 million (+177.24%) on 30 September 2024. Over the past year, it has increased by +$90.15 million (+12751.06%). IOVA TTM revenue is now at all-time high.IOVA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IOVA Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +10000.0% | +10000.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
IOVA Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | at low | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5 years | at high | at low | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | at low | at high | >+9999.0% | at high | >+9999.0% |
Iovance Biotherapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $58.55 M(+88.2%) | $90.86 M(+177.2%) |
| June 2024 | - | $31.11 M(+4250.5%) | $32.77 M(+1621.2%) |
| Mar 2024 | - | $715.00 K(+48.3%) | $1.90 M(+60.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $1.19 M | $482.00 K(+2.8%) | $1.19 M(+68.2%) |
| Sept 2023 | - | $469.00 K(+97.1%) | $707.00 K(+197.1%) |
| June 2023 | - | $238.00 K | $238.00 K |
FAQ
- What is Iovance Biotherapeutics annual revenue?
- What is the all time high annual revenue for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly revenue?
- What is the all time high quarterly revenue for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly revenue year-on-year change?
- What is Iovance Biotherapeutics TTM revenue?
- What is the all time high TTM revenue for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics TTM revenue year-on-year change?
What is Iovance Biotherapeutics annual revenue?
The current annual revenue of IOVA is $1.19 M
What is the all time high annual revenue for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual revenue is $1.19 M
What is Iovance Biotherapeutics quarterly revenue?
The current quarterly revenue of IOVA is $58.55 M
What is the all time high quarterly revenue for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly revenue is $58.55 M
What is Iovance Biotherapeutics quarterly revenue year-on-year change?
Over the past year, IOVA quarterly revenue has changed by +$58.09 M (+12384.86%)
What is Iovance Biotherapeutics TTM revenue?
The current TTM revenue of IOVA is $90.86 M
What is the all time high TTM revenue for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high TTM revenue is $90.86 M
What is Iovance Biotherapeutics TTM revenue year-on-year change?
Over the past year, IOVA TTM revenue has changed by +$90.15 M (+12751.06%)